Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 19630739)

1.
2.

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Kew JN, Kemp JA.

Psychopharmacology (Berl). 2005 Apr;179(1):4-29. Epub 2005 Feb 25. Review. Erratum in: Psychopharmacology (Berl). 2005 Oct;182(2):320.

PMID:
15731895
3.

Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors.

Marino MJ, Conn PJ.

Curr Opin Pharmacol. 2006 Feb;6(1):98-102. Epub 2005 Dec 20. Review.

PMID:
16368268
4.

Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.

Tharmalingam S, Burns AR, Roy PJ, Hampson DR.

Neuropharmacology. 2012 Sep;63(4):667-74. doi: 10.1016/j.neuropharm.2012.05.029. Epub 2012 May 28.

PMID:
22652059
5.

The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.

Koltunowska D, Gibula-Bruzda E, Kotlinska JH.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:242-9. doi: 10.1016/j.pnpbp.2013.04.013. Epub 2013 Apr 24.

PMID:
23623810
6.

Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.

Gannon RL, Millan MJ.

Neuropharmacology. 2011 Feb-Mar;60(2-3):209-15. doi: 10.1016/j.neuropharm.2010.08.022. Epub 2010 Sep 8.

PMID:
20831878
7.

Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Olive MF.

Eur J Pharmacol. 2010 Aug 10;639(1-3):47-58. doi: 10.1016/j.ejphar.2010.01.029. Epub 2010 Apr 2. Review.

8.
9.

Metabotropic glutamatergic receptors and their ligands in drug addiction.

Pomierny-ChamioĊ‚o L, Rup K, Pomierny B, Niedzielska E, Kalivas PW, Filip M.

Pharmacol Ther. 2014 Jun;142(3):281-305. doi: 10.1016/j.pharmthera.2013.12.012. Epub 2013 Dec 19. Review.

PMID:
24362085
10.
11.

Glutamate: the new frontier in pharmacotherapy for cocaine addiction.

Uys JD, LaLumiere RT.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):482-91. Review.

PMID:
19128205
12.

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Palucha A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. Review.

PMID:
17107280
13.

Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.

Nakazato A, Kumagai T, Sakagami K, Yoshikawa R, Suzuki Y, Chaki S, Ito H, Taguchi T, Nakanishi S, Okuyama S.

J Med Chem. 2000 Dec 14;43(25):4893-909.

PMID:
11123999
14.

Postsynaptic and presynaptic group II metabotropic glutamate receptor activation reduces neuronal excitability in rat midline paraventricular thalamic nucleus.

Hermes ML, Renaud LP.

J Pharmacol Exp Ther. 2011 Mar;336(3):840-9. doi: 10.1124/jpet.110.176149. Epub 2010 Dec 7.

15.

Neuroprotective activity of metabotropic glutamate receptor ligands.

Flor PJ, Battaglia G, Nicoletti F, Gasparini F, Bruno V.

Adv Exp Med Biol. 2002;513:197-223. Review.

PMID:
12575822
16.

Role of metabotropic glutamate receptors in the control of neuroendocrine function.

Durand D, Pampillo M, Caruso C, Lasaga M.

Neuropharmacology. 2008 Sep;55(4):577-83. doi: 10.1016/j.neuropharm.2008.06.022. Epub 2008 Jun 20. Review.

PMID:
18616955
17.
18.
19.

Metabotropic glutamate receptors in the main olfactory bulb drive granule cell-mediated inhibition.

Heinbockel T, Laaris N, Ennis M.

J Neurophysiol. 2007 Jan;97(1):858-70. Epub 2006 Nov 8.

20.

A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.

O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL Jr.

Mol Pharmacol. 2003 Sep;64(3):731-40.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk